Mylan has launched Rivastigmine Transdermal System, a generic version of Novartis’ Exelon Patch, for the treatment of patients suffering from dementia in the US.
Perrigo announced that Sun Pharmaceutical and MiCal Pharmaceuticals initiated patent litigations on May 9 and 10, 2018, in the U.S. District Court for the District of Delaware
Perrigo Company announced the prescription pharmaceutical launch of testosterone topical solution, 30 mg/1.5 mL (CIII), the generic equivalent to Eli Lilly and Company's Axiron Topical Solution, 30 mg/1.5 mL (CIII).